New CRISPR therapy is poised to gain first FDA approval to alter genes inside the body
A single infusion that edits a gene directly inside a patient's liver appears to keep working four years later, according to its developer, Intellia Therapeutics. The treatment now awaits a decision from the US Food and Drug Administration (FDA). If it is approved, it would become the world's first CRISPR medicine delivered straight into [...]









